Bank Regulation Rollbacks in the U.S. and UK Could Increase Financial Risks, Study Warns 
Oil Prices Rise as US-Iran Tensions Threaten Strait of Hormuz Oil Shipments 
Oil Prices Rebound as Strait of Hormuz Tensions Return After Ship Attack Near Oman 
Wall Street Ends Lower as AI Stocks Drag Markets, Fed Rate Outlook Shifts 
Asian Stocks Slip as US-Iran Ceasefire Hopes Lift Oil, Dollar Strength Persists 
US Dollar Slips After PCE Inflation Data Eases Fed Rate Hike Expectations 
S&P Affirms Brazil’s BB Credit Rating with Stable Outlook Amid Fiscal Challenges 
Economic pessimism has set in – but there are reasons for Australians to be hopeful 
SpaceX Eyes Starlink Mobile Phone Service to Challenge Verizon, AT&T, and T-Mobile 
Japan Targets 1%+ Real Economic Growth With ¥370 Trillion Investment Plan 
Gold Prices Fall Below $4,000 as Strong Dollar, Fed Rate Hike Bets Weigh on Bullion 
US Dollar Slips After PCE Inflation Data as Fed Rate Hike Expectations Stay Elevated 
Gold Prices Rise Above $4,000 as Inflation Data and Weaker Dollar Boost Demand 
Canada Grants C$7 Million to Greenland Molybdenum Mine to Strengthen Critical Minerals Supply 
China Sets 1.25% Overnight Reverse Repo Rate Below Market Expectations 
Wall Street Ends Mixed as Micron Surges, Apple Drops After Price Hikes 
South Korea’s KOSPI Plunges as Apple Price Hikes and OpenAI IPO Delay Shake AI Chip Stocks 
Olympus Corp CEO Resigns Following Allegations
Olympus Corp, the renowned Japanese endoscope manufacturer, announced on Monday that Chief Executive Officer Stefan Kaufmann has resigned after allegations surfaced regarding his purchase of illegal drugs. This development has caused a 6% decline in the company's shares, marking the steepest drop in nearly three months.
Kaufmann, a German national, took over the CEO role in April 2023 intending to enhance Olympus's medical equipment division. He succeeded Yasuo Takeuchi, who had successfully navigated the company through extensive asset sales during his tenure.
In a company statement, Olympus disclosed that upon receiving the allegations against Kaufmann, it promptly consulted with external legal counsel and launched an investigation. The investigation's findings led the Board of Directors to unanimously conclude that Kaufmann likely engaged in behavior contrary to the company's global code of conduct and core values.
Kaufmann, 56, was asked to resign and complied with the request. As Olympus grapples with this latest scandal, Yasuo Takeuchi will temporarily reassume the CEO role.
The impact of Kaufmann's departure was evident in the stock market, as Olympus shares have seen a notable increase of 35% over the past year, outperforming the Nikkei 225 index, which rose by 24%.
This incident is not Olympus's first encounter with controversy; thirteen years ago, former CEO Michael Woodford exposed significant accounting fraud involving inflated acquisition costs to conceal financial losses. Woodford's subsequent firing sparked a turbulent battle for control of the company.
